FRS2 and neoplasm: Fibroblast growth factor receptor substrate 2 (FRS2) phosphorylation was apparent in tumor specimens from vehicle-treated animals but absent in tumors from BGJ398-treated animals, indicating adequate BGJ398 dose administration (Fig. 7B).